NKTR News

Form 8-K

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE) Announced by Holzer & Holzer, LLC

52-Week Topline Results from 16-Week Blinded Treatment Extension of REZOLVE-AA Demonstrate Deepening of Responses in Severe-to-Very-Severe Alopecia Areata with Rezpegaldesleukin

NKTR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Shareholders Have Opportunity to Lead Class Action Lawsuit!

Class Action Filed by Pomerantz LLP Against Nektar Therapeutics – NKTR

Nektar Therapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NKTR

Pomerantz LLP Pursues Class Action Lawsuit Against Nektar Therapeutics – NKTR

ROSEN, A TOP-RANKED LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR

Pomerantz LLP Files Class Action Lawsuit Against Nektar Therapeutics – NKTR

NKTR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Investors with Losses Have Opportunity to Lead Class Action Lawsuit!